This Midsize-Company Growth Fund Keeps Beating the Market
Akre Focus' "three-legged stool" approach seems to be working.
It’s been a rough year for the U.S. stock market, but Akre Focus (AKREX) is hanging tough. The fund’s one-year return of 4.3% outpaced Standard & Poor’s 500-stock index by 4.9 percentage points and the average midsize-company growth fund (the category to which Morningstar assigns Akre) by 3.4 points. If Akre finishes the year ahead of the S&P 500, it will mark the fifth time in its six full years of existence that it topped or matched the market (Akre nipped the index by 0.04 percentage point in 2012).